SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Diez O) "

Sökning: WFRF:(Diez O)

  • Resultat 61-70 av 136
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
61.
  •  
62.
  •  
63.
  •  
64.
  •  
65.
  • Caplat, Paul, et al. (författare)
  • Sophia Title
  • 2013
  • Ingår i: Oikos. - : Wiley. - 1600-0706 .- 0030-1299. ; 122:9, s. 1265-1274
  • Tidskriftsartikel (refereegranskat)abstract
    • Synthesis Prediction and management of species responses to climate change is an urgent but relatively young research field. Therefore, climate change ecology must by necessity borrow from other fields. Invasion ecology is particularly well-suited to informing climate change ecology because both invasion ecology and climate change ecology address the trajectories of rapidly changing novel systems. Here we outline the broad range of active research questions in climate change ecology where research from invasion ecology can stimulate advances. We present ideas for how concepts, case-studies and methodology from invasion ecology can be adapted to improve prediction and management of species responses to climate change. A major challenge in this era of rapid climate change is to predict changes in species distributions and their impacts on ecosystems, and, if necessary, to recommend management strategies for maintenance of biodiversity or ecosystem services. Biological invasions, studied in most biomes of the world, can provide useful analogs for some of the ecological consequences of species distribution shifts in response to climate change. Invasions illustrate the adaptive and interactive responses that can occur when species are confronted with new environmental conditions. Invasion ecology complements climate change research and provides insights into the following questions: 1) how will species distributions respond to climate change? 2) how will species movement affect recipient ecosystems? And 3) should we, and if so how can we, manage species and ecosystems in the face of climate change? Invasion ecology demonstrates that a trait-based approach can help to predict spread speeds and impacts on ecosystems, and has the potential to predict climate change impacts on species ranges and recipient ecosystems. However, there is a need to analyse traits in the context of life-history and demography, the stage in the colonisation process (e.g. spread, establishment or impact), the distribution of suitable habitats in the landscape, and the novel abiotic and biotic conditions under which those traits are expressed. As is the case with climate change, invasion ecology is embedded within complex societal goals. Both disciplines converge on similar questions of when to intervene? and what to do? which call for a better understanding of the ecological processes and social values associated with changing ecosystems.
  •  
66.
  • Coignard, J, et al. (författare)
  • A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
  • 2021
  • Ingår i: Nature communications. - : Springer Science and Business Media LLC. - 2041-1723. ; 12:1, s. 1078-
  • Tidskriftsartikel (refereegranskat)abstract
    • Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10−8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
  •  
67.
  •  
68.
  •  
69.
  • Couch, Fergus J., et al. (författare)
  • Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
  • 2016
  • Ingår i: Nature Communications. - : NATURE PUBLISHING GROUP. - 2041-1723. ; 7:11375, s. 1-13
  • Tidskriftsartikel (refereegranskat)abstract
    • Common variants in 94 loci have been associated with breast cancer including 15 loci with genome-wide significant associations (P<5 x 10(-8)) with oestrogen receptor (ER)-negative breast cancer and BRCA1-associated breast cancer risk. In this study, to identify new ER-negative susceptibility loci, we performed a meta-analysis of 11 genome-wide association studies (GWAS) consisting of 4,939 ER-negative cases and 14,352 controls, combined with 7,333 ER-negative cases and 42,468 controls and 15,252 BRCA1 mutation carriers genotyped on the iCOGS array. We identify four previously unidentified loci including two loci at 13q22 near KLF5, a 2p23.2 locus near WDR43 and a 2q33 locus near PPIL3 that display genome-wide significant associations with ER-negative breast cancer. In addition, 19 known breast cancer risk loci have genome-wide significant associations and 40 had moderate associations (P<0.05) with ER-negative disease. Using functional and eQTL studies we implicate TRMT61B and WDR43 at 2p23.2 and PPIL3 at 2q33 in ER-negative breast cancer aetiology. All ER-negative loci combined account for similar to 11% of familial relative risk for ER-negative disease and may contribute to improved ER-negative and BRCA1 breast cancer risk prediction.
  •  
70.
  • Cunningham, A. L., et al. (författare)
  • Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
  • 2016
  • Ingår i: New England Journal of Medicine. - 0028-4793 .- 1533-4406. ; 375:11, s. 1019-1032
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND A trial involving adults 50 years of age or older (ZOE-50) showed that the herpes zoster subunit vaccine (HZ/su) containing recombinant varicella-zoster virus glycoprotein E and the AS01(B) adjuvant system was associated with a risk of herpes zoster that was 97.2% lower than that associated with placebo. A second trial was performed concurrently at the same sites and examined the safety and efficacy of HZ/su in adults 70 years of age or older (ZOE-70). METHODS This randomized, placebo-controlled, phase 3 trial was conducted in 18 countries and involved adults 70 years of age or older. Participants received two doses of HZ/su or placebo (assigned in a 1: 1 ratio) administered intramuscularly 2 months apart. Vaccine efficacy against herpes zoster and postherpetic neuralgia was assessed in participants from ZOE-70 and in participants pooled from ZOE-70 and ZOE-50. RESULTS In ZOE-70, 13,900 participants who could be evaluated (mean age, 75.6 years) received either HZ/su (6950 participants) or placebo (6950 participants). During a mean follow-up period of 3.7 years, herpes zoster occurred in 23 HZ/su recipients and in 223 placebo recipients (0.9 vs. 9.2 per 1000 person-years). Vaccine efficacy against herpes zoster was 89.8% (95% confidence interval [CI], 84.2 to 93.7; P<0.001) and was similar in participants 70 to 79 years of age (90.0%) and participants 80 years of age or older (89.1%). In pooled analyses of data from participants 70 years of age or older in ZOE-50 and ZOE-70 (16,596 participants), vaccine efficacy against herpes zoster was 91.3% (95% CI, 86.8 to 94.5; P<0.001), and vaccine efficacy against postherpetic neuralgia was 88.8% (95% CI, 68.7 to 97.1; P<0.001). Solicited reports of injection-site and systemic reactions within 7 days after injection were more frequent among HZ/su recipients than among placebo recipients (79.0% vs. 29.5%). Serious adverse events, potential immune-mediated diseases, and deaths occurred with similar frequencies in the two study groups. CONCLUSIONS In our trial, HZ/su was found to reduce the risks of herpes zoster and postherpetic neuralgia among adults 70 years of age or older. (Funded by GlaxoSmithKline Biologicals; ZOE-50 and ZOE-70 ClinicalTrials.govnumbers, NCT01165177 and NCT01165229.)
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 61-70 av 136
Typ av publikation
tidskriftsartikel (123)
konferensbidrag (6)
forskningsöversikt (3)
Typ av innehåll
refereegranskat (120)
övrigt vetenskapligt/konstnärligt (12)
Författare/redaktör
Radice, P (33)
Nevanlinna, H (33)
Osorio, A. (33)
Diez, O (33)
Hamann, U (32)
Chenevix-Trench, G (32)
visa fler...
McGuffog, L. (32)
Thomassen, M. (32)
Offit, K. (32)
Montagna, M. (32)
Peterlongo, P (31)
Andrulis, IL (31)
Simard, J (31)
Antoniou, AC (31)
Olah, E (31)
Godwin, AK (31)
Neuhausen, SL (31)
Greene, MH (31)
Benitez, J. (30)
Couch, FJ (30)
Jakubowska, A (30)
Meindl, A (30)
Nathanson, KL (30)
Easton, DF (29)
Singer, CF (29)
Barrowdale, D (29)
Manoukian, S (28)
Toland, AE (28)
Stoppa-Lyonnet, D. (28)
Caligo, MA (28)
Karlan, BY (28)
Tischkowitz, M (28)
Schmutzler, RK (27)
Goldgar, DE (27)
Janavicius, R (27)
Friedman, E. (26)
Lubinski, J (26)
Buys, SS (26)
John, EM (26)
Frost, D. (26)
Caldes, T. (26)
Teixeira, MR (25)
Wappenschmidt, B. (25)
Engel, C. (25)
Domchek, SM (25)
Rantala, J. (24)
Lazaro, C. (24)
Soucy, P (24)
van Rensburg, EJ (24)
Daly, MB (24)
visa färre...
Lärosäte
Karolinska Institutet (89)
Lunds universitet (40)
Uppsala universitet (21)
Göteborgs universitet (19)
Umeå universitet (14)
Stockholms universitet (11)
visa fler...
RISE (5)
Sveriges Lantbruksuniversitet (3)
Kungliga Tekniska Högskolan (2)
Mittuniversitetet (2)
Linnéuniversitetet (2)
Naturhistoriska riksmuseet (2)
Linköpings universitet (1)
Chalmers tekniska högskola (1)
IVL Svenska Miljöinstitutet (1)
visa färre...
Språk
Engelska (136)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (77)
Naturvetenskap (20)
Lantbruksvetenskap (5)
Teknik (1)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy